Scientists develop a new non-opioid pain killer with fewer side effects

• Promising compound benzyloxy-cyclopentyladenosine (BnOCPA) found to be a potent and selective pain killer in test model systems
• BnOCPA is also selective in its action, and non-addictive, opening up the potential for the development of potent analgesics without side effects
• Results revealed in paper published by scientists at the University of Warwick, University of Cambridge, University of Bern, Monash University, Coventry University and industrial partners

A promising new non-opioid painkiller (analgesic) with potentially fewer side effects compared to other potent painkillers, has been discovered.